스크랩 비타민 C가 왜 코로나바이러스 치료에 특효인가, 먹든지 정맥주사를 맞든지

[무랑]

비타민 C가 왜 코로나바이러스 치료에 특효인가, 먹든지 정맥주사를 맞든지

Three Intravenous Vitamin C Research Studies Approved for Treating COVID-19

by Andrew W. Saul, Editor

정맥 내 비타민 C는 이미 COVID-19 코로나 바이러스에 대해 중국에서 사용되고 있습니다. 국제 정맥 비타민 C 중국 전염병 의료 지원 팀의 의료 및 과학 자문위원회의 일원이기 때문에 정기적으로 업데이트를 받고 있습니다. 그곳의 국장은 리차드 쳉 입니다 Richard Z. Cheng, MD, PhD;

그곳의 부국장은 홍장 박사입니다. 다른 팀원 중에는 치첸 Qi Chen 박사 (캔자스 대학교 의과 대학 부교수); Jeanne Drisko, MD (캔자스 의과 대학 교수); Thomas E. Levy, MD, JD; 및 Atsuo Yanagisawa, MD, PhD. (도쿄 교린 대학 교수)이있다. 치료 프로토콜 정보를 영어로 읽으려면 다음 링크를 보세요:

http://orthomolecular.org/resources/omns/v16n07.shtml (Protocol in Chinese at http://www.doctoryourself.com/Coronavirus_Chinese_IV_C_Protocol.pdf

(OMNS February 21, 2020) Intravenous vitamin C is already being employed in China against COVID-19 coronavirus. I am receiving regular updates because I am part of the Medical and Scientific Advisory Board to the International Intravenous Vitamin C China Epidemic Medical Support Team. Its director is Richard Z. Cheng, MD, PhD; 

associate director is Hong Zhang, PhD. Among other team members are Qi Chen, PhD (Associate Professor, Kansas University Medical School); Jeanne Drisko, MD (Professor, University of Kansas Medical School); Thomas E. Levy, MD, JD; and Atsuo Yanagisawa, MD, PhD. (Professor, Kyorin University, Tokyo). To read the treatment protocol information in English: http://orthomolecular.org/resources/omns/v16n07.shtml (Protocol in Chinese at http://www.doctoryourself.com/Coronavirus_Chinese_IV_C_Protocol.pdf

중국에서의 직접 보고서  Direct report from China

OMNS 중국어판 편집자 인 쳉 Richard Cheng 박사는 IV가 12,000 ~ 24,000mg / day의 비타민 C를 최초로 승인한 연구에 대해 중국에서 보고하고 있습니다. 의사는 또한 코로나 바이러스 예방을 위해 비타민 C를 즉시 사용해야 합니다 (COVID-19).

OMNS Chinese edition editor Dr. Richard Cheng is reporting from China about the first approved study of 12,000 to 24,000 mg/day of vitamin C by IV. The doctor also specifically calls for immediate use of vitamin C for prevention of coronavirus (COVID-19). https://www.youtube.com/watch?v=TC0SO9KDG7U

A second clinical trial of intravenous vitamin C was announced in China on Feb. 13th. In this second study, says Dr. Cheng, "They plan to give 6,000 mg/day and 12,000 mg/day per day for moderate and severe cases. We are also communicating with other hospitals about starting more intravenous vitamin C clinical studies. We would like to see oral vitamin C included in these studies, as the oral forms can be applied to more patients and at home." Additional information at http://orthomolecular.org/resources/omns/v16n11.shtml

그리고 2020 년 2 월 21 일, COVID-19의 정맥 내 비타민 C에 대해 승인 된 세 번째 연구 시험이 발표되었습니다.

And on Feb 21, 2020, announcement has been made of a third research trial now approved for intravenous vitamin C for COVID-19. https://www.youtube.com/watch?v=VMDX0RSDp1k&feature=youtu.be

노화 방지 의학의 미국 보드 인증 전문가인 쳉 Cheng 박사는 다음과 같이 덧붙입니다. "비타민 C는 예방에 매우 유망하며, 더 나은 치료가 없을 때 죽어가는 환자를 치료하는 데 특히 중요합니다. 2,000 명 이상이 COIV-19가 발생한 이후 사망했지만, 아직 어떤 경우에도 다량의 정맥 내 비타민 C가 사용되는 것을 보거나 듣지 못했습니다. 현재 전염병을 위한 백신과 특정 항 바이러스 약물에 중점을 두고 있는데, 이는 잘못된 일입니다. "

"초기에 충분한 양의 정맥 내 비타민 C 주입이 중요합니다. 비타민 C는 프로토 타입 항 산화제일뿐만 아니라 바이러스 살해 및 바이러스 복제의 예방에도 관여한다. 다량의 정맥 내 비타민 C의 중요성은 항 바이러스 수준이며 : 급성 호흡곤란 증후군 (ARDS)은 대부분의 사람들을 관상 동맥류 전염병 (SARS, MERS 및 현재 NCP)으로 인해 죽게만듭니다 ARDS는 사망으로 이어지는 일반적인 최종 경로입니다.

"따라서 우리는 이 주제에 대한 세계적인 토의와 토론을 요구합니다."

Dr. Cheng, who is a US board-certified specialist in anti-aging medicine, adds: "Vitamin C is very promising for prevention, and especially important to treat dying patients when there is no better treatment. Over 2,000 people have died of the COIV-19 outbreak and yet I have not seen or heard large dose intravenous vitamin C being used in any of the cases. The current sole focus on vaccine and specific antiviral drugs for epidemics is misplaced."

He adds that: "Early and sufficiently large doses of intravenous vitamin C are critical. Vitamin C is not only a prototypical antioxidant, but also involved in virus killing and prevention of viral replication. The significance of large dose intravenous vitamin C is not just at antiviral level. It is acute respiratory distress syndrome (ARDS) that kills most people from coronaviral pandemics (SARS, MERS and now NCP). ARDS is a common final pathway leading to death.

"We therefore call for a worldwide discussion and debate on this topic."

코로나 19 사태에서 비타민 C가 특효있다는 연구결과 뉴스는 고의적으로 억제되었다

News of vitamin C research for COVID-19 is being actively suppressed

비타민 요법이 코로나 바이러스를 막을 수 있다고 말하는 사람은 이미 "거짓 정보 홍보"로 찍히고 "가짜 뉴스"라고 경원시됩니다. 검증 가능한 뉴스와 자격을 갖춘 의료 전문가의 직접적인 인용조차도 소셜 미디어에서 제한되거나 차단되고 있습니다. 내 Facebook 페이지에서 이 현상의 순차적인 사례를 볼 수 있습니다. 메가비타민 사례를 요.

https://www.facebook.com/themegavitaminman .

Anyone saying that vitamin therapy can stop coronavirus is already being labeled as "promoting false information" and promulgating "fake news." Even the sharing of verifiable news, and direct quotes from credentialed medical professionals, is being restricted or blocked on social media. You can see sequential examples of this phenomenon at my Facebook page https://www.facebook.com/themegavitaminman .

Indeed, the World Health Organization (WHO) has, literally, met with Google and Facebook and other media giants to stop the spread of what they declare to be wrong information. https://www.cnbc.com/amp/2020/02/14/facebook-google-amazon-met-with-who-to-talk-coronavirus-misinformation.html?__twitter_impression=true

Physician-directed, hospital-based administration of intravenous vitamin C has been marginalized or discredited. Scientific debate over COVID-19 appears to not be allowed.

Ironically, Facebook, blocking any significant users' sharing of the news of approved vitamin therapy research, is itself blocked in China by the Chinese government. As for the internet, yes, China has it. And yes, it is censored. But, significantly, the Chinese government has not blocked this real news on how intravenous vitamin C will save lives in the COVID-19 epidemic. Here is the protocol as published in Chinese: http://orthomolecular.org/resources/omns/v16n11-chi.shtml

Medical orthodoxy obsessively focuses on searching for a vaccine and/or drug for coronavirus COVID-19). While they are looking for what would be fabulously profitable approaches, we have with vitamin C an existing, plausible, clinically demonstrated method to treat what coronavirus patients die from: severe acute respiratory syndrome, or pneumonia.

And it is available right now.

To read all Orthomolecular Medicine News Service Reports on COVID coronavirus and intravenous vitamin C:

Vol. 16, No. 04	January 26, 2020	Vitamin C Protects Against Coronavirus
Vol. 16, No. 06	January 30, 2020	Nutritional Treatment of Coronavirus
Vol. 16, No. 07	February 2, 2020	Hospital-based Intravenous Vitamin C Treatment for Coronavirus and Related Illnesses
Vol. 16, No. 09	February 10, 2020	VITAMIN C AND ITS APPLICATION TO THE TREATMENT OF nCoV CORONAVIRUS: How Vitamin C Reduces Severity and Deaths from Seriou